2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Head & Neck
1
Endocrine
1
Classical hematology
1
Conditions
Ovarian Neoplasms
3168
Uterine Cervical Neoplasms
2191
Endometrial Neoplasms
1334
Breast Neoplasms
819
Fallopian Tube Neoplasms
808
Carcinoma, Ovarian Epithelial
772
Neoplasms
540
Colorectal Neoplasms
439
Carcinoma, Non-Small-Cell Lung
420
Uterine Cervical Dysplasia
376
Pancreatic Neoplasms
363
Stomach Neoplasms
354
Prostatic Neoplasms
318
Lung Neoplasms
315
Melanoma
289
Uterine Neoplasms
239
Peritoneal Neoplasms
238
Neoplasm Metastasis
238
Vulvar Neoplasms
229
Urinary Bladder Neoplasms
225
Esophageal Neoplasms
225
Head and Neck Neoplasms
222
Sarcoma
219
Carcinoma, Renal Cell
214
Recurrence
213
Colonic Neoplasms
210
Papillomavirus Infections
206
Triple Negative Breast Neoplasms
191
Squamous Cell Carcinoma of Head and Neck
177
Vaginal Neoplasms
147
Interventions
Colposcopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Sexually Transmitted Diseases, Viral
×
Gynecologic
×
Clear all
NCT07281599
2026-02-02
EQUIP
Qurasense
Phase NA
Recruiting
450 enrolled
NCT05225493
2022-02-04
#AwareHIV
Erasmus Medical Center
Unknown
1,500 enrolled